Interestingly, VEGFR2 could also act as the downstream driver gene of circRNA-MYLK when binding to miR-29a and relieving its suppression for VEGFA, and promote Ras/ERK signaling pathway in bladder cancer [15]. This evidence concerns the gene MYLK and urinary bladder cancer.